Outset Medical Inc (OM) - Net Profit

Official company branding of Outset Medical Inc (OM)

The price action of Outset Medical, Inc. (OM) on the GURU.Markets platform shows a current value of -0.07. Outset Medical, Inc. is developing component supply chains for dialysis systems, expanding its circle of counterparties to ensure stable production. The business relies on serving hospitals and individuals with renal pathologies, offering advanced Tablo mobile units for home or inpatient therapy.

Outset Medical, Inc. (OM) - Net Profit from 07/04/2022 to 10/29/2026

Comprehensive metric breakdowns and analytics for Outset Medical (OM)

- stock value and consensus price forecast:
Market Price Outset Medical Corp|OM - Consensus Target
- market capitalization indicators:
Market Capitalization Outset Medical Corp|OM - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share Outset Medical|OM - Book Capitalization|Market Capitalization to Book Value outsetmedical.com|OM - Company Total Assets
- debt and solvency information:
Total Debt to Equity Ratio Outset Medical, Inc.|OM - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Outset Medical Inc|OM - Company Debts|Debt to Book Value Outset Medical Corp|OM - Company Long-Term Debts|Short-Term Debt Outset Medical|Immediate Liquidity Ratio outsetmedical.com
- earnings and valuation multiples indicators:
OM - Net Profit
Basic company analysis:OM, Outset Medical Corp
Core merchandise of Outset Medical Inc

Investors must find a balance between operational risks and the actual return on invested capital. The success of Outset Medical, Inc. (OM) depends on scaling the Tablo system and increasing recurring sales of consumables. By analyzing the net income dynamics of Outset Medical, Inc. (OM), one can assess the impact of Fed liquidity on the final financial result. This metric measures the business's ability to generate profit above all costs. Stable growth in this indicator would confirm the resilience of the business model and a reduction in clinic expenses.

Direct competitors

Company Net Income Dexcom CGM (DXCM)|Net Income PEN|Net Profit novanta.com|Net Income HAE (Haemonetics)|Profit After Payment of Taxes INSP|Net Profit PRCT (PROCEPT BioRobotics Inc)|Net Financial Result CONMED Inc. (CNMD)|Pulse Biosciences, Inc. - Net Profit|inmodemd.com (INMD) - Net Income|PMI (Picard Medical) - Net Income|Surmodics Inc - Final Profit|Company Net Income Senseonics Holdings|Net Income NeuroPace Medical (NPCE)|Net Profit TCMD|SNWV - Company Net Income|Net Profit ELMD (Electromed)|LNSR: Company Profit|AVITA Medical, Inc - Net Profit|Net Financial Result Profound Medical Corp. PROF|BDMD: Net Profit|Net Income EDAP TMS|APYX (Apyx Medical Corp) - Net Profit|Net Profit IceCure Medical, Ltd.|Company Net Income Pulmonx Corporation (LUNG)|Company Net Income TELA (telabio.com)|CytoSorbents Corporation - Net Income|Final Profit SRTS|Zynex - Net Profit|Company Net Income electroCore, Inc.|vicarioussurgical.com (RBOT) - Company Net Income|Annual Net Income Inspira Technologies IINN|Net Income ICU|Net Profit IRIDEX Corp.|Net Profit INBS|Net Financial Result beyondair.net|Company Net Income Profusa, Inc. PFSA|SSKN (STRATA Skin Sciences Inc.) - Profit After Tax|GCTK - Company Net Income|NanoVibronix Inc. (NAOV) - Net Income|VERO: Net Profit|Company Net Income Nuwellis Inc (NUWE)|Company Net Income Aethlon|Company Profit ASXC (TransEnterix)|Net Income AVGR (Avinger, Inc.)|Profit After Payment of Taxes BSGM|Company Net Income Cutera CUTR|Know Labs Inc (KNW) - Company Net Income|NARI: Net Income|NVRO - Net Profit|RSLS (reshapelifesciences.com) - Net Income|SILK: Profit After Payment of Taxes